Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Microsoft
MSFT
|
+$633M |
| 3 |
Alibaba
BABA
|
+$501M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$484M |
| 5 |
Apple
AAPL
|
+$456M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$622M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$597M |
| 3 |
Comcast
CMCSA
|
+$461M |
| 4 |
UnitedHealth
UNH
|
+$409M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.08% |
| 2 | Consumer Discretionary | 2.25% |
| 3 | Financials | 2.23% |
| 4 | Healthcare | 2.22% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
7801
DELISTED
Inozyme Pharma
INZY
| $1.09M | ﹤0.01% |
94,466
-76,600
| -45% | -$1.19M |
|
|
OTRK
7802
PUT
DELISTED
Ontrak
OTRK
| $1.09M | ﹤0.01% |
1,212
+270
| +29% | +$482K |
|
7803
ProShares MSCI Transformational Changes ETF
ANEW
$7.94M
| $1.09M | ﹤0.01% |
24,496
+13,327
| +119% | +$619K |
|
7804
iShares iBonds Dec 2028 Term Treasury ETF
IBTI
$1.97B
| $1.09M | ﹤0.01% |
+43,099
| New | +$1.11M |
|
|
NIU
7805
CALL
Niu Technologies
NIU
$159M
| $1.09M | ﹤0.01% |
47,200
-4,400
| -9% | -$117K |
|
7806
PUT
Perdoceo Education
PRDO
$2.04B
| $1.09M | ﹤0.01% |
103,600
+48,600
| +88% | +$547K |
|
7807
Establishment Labs
ESTA
$2.24B
| $1.09M | ﹤0.01% |
15,273
-5,523
| -27% | -$407K |
|
7808
Fidelity Value Factor ETF
FVAL
$1.36B
| $1.09M | ﹤0.01% |
22,910
+10,485
| +84% | +$516K |
|
7809
CALL
OR Royalties Inc
OR
$6.05B
| $1.09M | ﹤0.01% |
97,200
-4,500
| -4% | -$56.3K |
|
7810
Talos Energy
TALO
$2.73B
| $1.09M | ﹤0.01% |
79,267
-59,262
| -43% | -$722K |
|
7811
Unitil
UTL
$983M
| $1.09M | ﹤0.01% |
25,494
+6,598
| +35% | +$330K |
|
|
FFHG
7812
DELISTED
Formula Folios Hedged Growth ETF
FFHG
| $1.09M | ﹤0.01% |
+31,048
| New | +$1.1M |
|
|
ISEE
7813
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.09M | ﹤0.01% |
67,200
+38,800
| +137% | +$422K |
|
7814
AdvanSix
ASIX
$447M
| $1.09M | ﹤0.01% |
27,418
+13,360
| +95% | +$459K |
|
|
CADE
7815
CALL
DELISTED
Cadence Bank
CADE
| $1.09M | ﹤0.01% |
36,600
+12,200
| +50% | +$340K |
|
7816
TechnipFMC
FTI
$30.7B
| $1.09M | ﹤0.01% |
144,765
-62,969
| -30% | -$453K |
|
7817
Advantage Solutions
ADV
$419M
| $1.09M | ﹤0.01% |
5,037
+92
| +2% | +$21.6K |
|
|
PKBO
7818
DELISTED
Peak Bio, Inc. Common Stock
PKBO
| $1.09M | ﹤0.01% |
111,259
-3,725
| -3% | -$36.1K |
|
7819
UVA Unconstrained Medium-Term Fixed Income ETF
FFIU
$52.5M
| $1.09M | ﹤0.01% |
41,238
-10,648
| -21% | -$284K |
|
7820
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.31B
| $1.09M | ﹤0.01% |
41,897
-83,703
| -67% | -$2.18M |
|
|
HAAC
7821
PUT
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
| $1.09M | ﹤0.01% |
111,200
-16,900
| -13% | -$165K |
|
7822
Sphere 3D
ANY
$16.7M
| $1.09M | ﹤0.01% |
2,613
+2,308
| +757% | +$741K |
|
7823
CALL
Choice Hotels
CHH
$4.82B
| $1.09M | ﹤0.01% |
8,600
+1,900
| +28% | +$227K |
|
7824
CALL
Vanguard Russell 2000 ETF
VTWO
$17.3B
| $1.09M | ﹤0.01% |
12,300
+8,600
| +232% | +$770K |
|
7825
PUT
Axcelis
ACLS
$4.18B
| $1.09M | ﹤0.01% |
23,100
+15,300
| +196% | +$666K |
|
Similar funds
Ken Griffin's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.
- Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
- Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
- Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
- Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
- Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
- Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
- Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.